Valo Health to Participate in Piper Sandler and Goldman Sachs Investor Conferences

BOSTON, Nov. 8, 2021 /PRNewswire/ -- Valo Health, LLC ("Valo"), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process, announced today that its CEO and founder, David Berry, will present at the following investor conferences in November and December:

EVENT: Piper Sandler 33^rd Annual Virtual Healthcare Conference
WHAT: A pre-recorded session with David Berry will be available for attendees
DATE: November 29, 2021

EVENT: Goldman Sachs Inaugural Investor Conference - Byte-ology: The Convergence of Biotechnology with Technology
WHAT: David Berry will join leaders from Recursion, Relay Therapeutics, Exscientia and Schrodinger in the Biotechnology Panel
DATE: December 9, 2021 10:00 am EST

About Valo Health

Valo Health, LLC (“Valo”) is a tech­nol­o­gy com­pa­ny built to trans­form the drug dis­cov­ery and devel­op­ment process using human-cen­tric data and arti­fi­cial intel­li­gence-dri­ven com­pu­ta­tion. As a dig­i­tal­ly native com­pa­ny, Valo aims to ful­ly inte­grate human-cen­tric data across the entire drug devel­op­ment life cycle into a sin­gle uni­fied archi­tec­ture, there­by accel­er­at­ing the dis­cov­ery and devel­op­ment of life-chang­ing drugs while simul­ta­ne­ous­ly reduc­ing costs, time, and fail­ure rates. The com­pa­ny’s Opal Com­pu­ta­tion­al Plat­form^™ is an inte­grat­ed set of capa­bil­i­ties designed to trans­form data into valu­able insights that may accel­er­ate dis­cov­er­ies and enable Valo to advance a robust pipeline of pro­grams across car­dio­vas­cu­lar meta­bol­ic renal, oncol­o­gy, and neu­rode­gen­er­a­tive dis­ease. Found­ed by Flagship Pioneering and head­quar­tered in Boston, MA, Valo also has offices in Lex­ing­ton, MA, San Fran­cis­co, CA, Prince­ton, NJ, and Bran­ford, CT. To learn more, vis­it www.valohealth.com

Contacts:
Investors: Graeme Bell, Chief Financial Officer
[email protected]